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 A high width of biological activity of natural or synthetic unsaturated five 
membered lactones from the family of furan-2(5H)-ones, is the main reason why to 
synthesize new substances of this structure. The introductory part of the thesis deals 
with antineoplastic natural compounds of this type. Except of antitumour activity some 
unsaturated five membered lactones exhibit antifungal, antiviral, antibacterial effects, or 
inhibit the synthesis of cholesterol, for example. 
 The experimental project is an extension of my diploma thesis concerned with the 
synthesis of precursors for lactones. These precursors – methyl (E)- and (Z)-2-bromo-5-
(subst.)arylpent-2-en-4-ynoates – were prepared by Sonogashira couplings. The parent 
substances for couplings were arylethynes (1-ethynyl-4-(methoxymethoxy)benzen, 
1-ethynyl-2-nitrobenzene, 3-ethynylaniline, 2-ethynylpyridine) and methylesters of 
dihalogenated prop-2-enoic acid. The dominant products of the couplings were 
β-monoalkynylated esters, apart from them side products of homocouplings were 
obtained.  
 Reactions of E-methylesters of dihalogenated prop-2-enoic acid afford higher or 
comparable yields than the corresponding Z-methylesters of dihalogenated prop-2-enoic 
acid.  E-isomers are stericly more suitable for couplings.  
 Only methyl (E)-2-bromo-5-(subst.)arylpent-2-en-4-ynoates are suitable for 
synthesis of potentially biologically active lactones because of steric reasons (these 
substances will be first hydrolyzed to acids, and the acids will be used for lactonization 
to 2-bromo-5-(subst.)arylmethylidenefuran-2(5H)-ones). The products of reactions with 
Z-isomers can serve as precursors for various other coumpounds.  
 The target compounds containing γ-butyrolactone moiety will be evaluated for 
their antineoplastic and antiviral activity. 
